GENEOSCOPY, INC. – Trademark Portfolio
Entity Type: 03
GENEOSCOPY, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 4 are pending. Notable registered marks include COLOSENSE and GENEOSCOPY. The owner is based in ST. LOUIS, MO.
2220 WELSCH INDUSTRIAL COURT
ST. LOUIS, MO 63146
Showing of trademarks Trademarks
Trademark Classifications
GENEOSCOPY, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GENEOSCOPY, INC. have?
GENEOSCOPY, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 pending, 3 abandoned.
What trademark classes does GENEOSCOPY, INC. file in?
GENEOSCOPY, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are GENEOSCOPY, INC.'s most well-known trademarks?
GENEOSCOPY, INC.'s registered trademark portfolio includes well-known marks such as COLOSENSE and GENEOSCOPY. These are among 2 currently registered trademarks in the portfolio.
What is GENEOSCOPY, INC.'s trademark registration success rate?
GENEOSCOPY, INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 4 applications are pending review.